Coronavirus Update: Korea Approval For Nuvaxovid, Japan Filing For Paxlovid
Executive Summary
More progress for vaccines and oral antivirals in Asia as South Korea issues an approval for Novavax's vaccine, Pfizer files for Japanese approval of Paxlovid, and SK bio progresses late-stage trials of its recombinant vaccine.